FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 49 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,458,000 | -22.6% | 1,040,000 | -7.1% | 0.10% | -25.0% |
| Q4 2020 | $8,344,000 | +22.9% | 1,120,000 | 0.0% | 0.13% | -3.8% |
| Q3 2020 | $6,787,000 | -27.4% | 1,120,000 | 0.0% | 0.13% | -34.5% |
| Q2 2020 | $9,352,000 | +118.7% | 1,120,000 | +55.6% | 0.20% | +46.0% |
| Q1 2020 | $4,277,000 | -8.3% | 720,000 | 0.0% | 0.14% | +6.1% |
| Q4 2019 | $4,666,000 | +34.7% | 720,000 | 0.0% | 0.13% | +14.9% |
| Q3 2019 | $3,463,000 | +20.2% | 720,000 | 0.0% | 0.11% | +29.5% |
| Q2 2019 | $2,880,000 | -17.5% | 720,000 | 0.0% | 0.09% | -26.7% |
| Q1 2019 | $3,492,000 | -24.0% | 720,000 | 0.0% | 0.12% | -40.9% |
| Q4 2018 | $4,594,000 | -24.4% | 720,000 | -2.9% | 0.20% | -9.0% |
| Q3 2018 | $6,078,000 | -21.5% | 741,175 | 0.0% | 0.22% | -30.5% |
| Q2 2018 | $7,738,000 | -13.6% | 741,175 | 0.0% | 0.32% | -23.6% |
| Q1 2018 | $8,961,000 | +21.3% | 741,175 | 0.0% | 0.42% | +9.1% |
| Q4 2017 | $7,390,000 | – | 741,175 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
| Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
| DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
| Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
| HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
| 683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
| Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |